PubMed=305224; DOI=10.7326/0003-4819-88-3-323
Saxon A., Stevens R.H., Golde D.W.
T-lymphocyte variant of hairy-cell leukemia.
Ann. Intern. Med. 88:323-326(1978)
PubMed=6984393
Gauwerky C.E., Lusis A.J., Golde D.W.
Erythroid-potentiating activity: characterization and target cells.
Exp. Hematol. 8 Suppl. 8:117-127(1980)
PubMed=6987658; DOI=10.1073/pnas.77.1.593
Golde D.W., Bersch N., Quan S.G., Lusis A.J.
Production of erythroid-potentiating activity by a human T-lymphoblast cell line.
Proc. Natl. Acad. Sci. U.S.A. 77:593-596(1980)
PubMed=6600440; DOI=10.1007/BF02617996
Uittenbogaart C.H., Cantor Y., Fahey J.L.
Growth of human malignant lymphoid cell lines in serum-free medium.
In Vitro 19:67-72(1983)
Patent=US4438032
Golde D.W., Quan S.G.
Unique T-lymphocyte line and products derived therefrom.
Patent number US4438032, 20-Mar-1984
CLPUB00468
Javitt G.
Why not take all of me? Reflections on the immortal life of Henrietta Lacks and the status of participants in research using human specimens.
Minn. J. Law Sci. Technol. 11:713-755(2010)
PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)
PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)